Doximity, Inc.

Equities

DOCS

US26622P1075

Internet Services

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
26.91 USD -0.30% Intraday chart for Doximity, Inc. -3.96% -4.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating MT
Leerink Partners Initiates Doximity at Market Perform Rating With $32 Price Target MT
Jefferies Raises Doximity's Price Target to $35 From $30, Buy Rating Kept MT
Wells Fargo Adjusts Price Target on Doximity to $27 From $25, Maintains Equalweight Rating MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on June 6, 2023. CI
Doximity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Doximity, Inc., Q3 2024 Earnings Call, Feb 08, 2024
Doximity Fiscal Q3 Non-GAAP EPS, Revenue Increase; Q4 Outlook Set; Shares Fall After Hours MT
Doximity Guides For Q4 Revenue of $115.9-$116.9 Million, vs CIQ Analyst Consensus of $118 Million MT
Earnings Flash (DOCS) DOXIMITY Reports Q3 Revenue $135.3M, vs. Street Est of $127.5M MT
Earnings Flash (DOCS) DOXIMITY Posts Q3 EPS $0.29, vs. Street Est of $0.24 MT
Doximity, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending March 31, 2024 CI
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on November 9, 2023. CI
BofA Securities Upgrades Doximity to Neutral From Underperform, Adjusts Price Target to $29 From $21 MT
Sector Update: Health Care Stocks Rising Late Afternoon MT
Sector Update: Health Care Stocks Rise Friday Afternoon MT
Sector Update: Health Care Stocks Advance Premarket Friday MT
Morgan Stanley Raises Price Target on Doximity to $25 From $21, Cites 'Solid Quarter,' Keeps Underweight Rating MT
North American Morning Briefing : Investors Weigh Higher-For-Longer Rates DJ
Transcript : Doximity, Inc., Q2 2024 Earnings Call, Nov 09, 2023
Doximity Fiscal Q2 Non-GAAP EPS, Revenue Rise; FY Revenue Forecast Boosted; Buyback Set; Shares Jump After Hours MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on November 10, 2022. CI
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on June 6, 2023. CI
Doximity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Doximity Guides For Q3 Revenue of $127-$128 Million, vs CIQ Analyst Consensus of $123 Million; FY 2024 Revenue Seen at $460-$472 Million, vs Consensus of $461 Million MT
Chart Doximity, Inc.
More charts
Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company's cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company's platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
26.99 USD
Average target price
29.92 USD
Spread / Average Target
+10.87%
Consensus
  1. Stock
  2. Equities
  3. Stock Doximity, Inc. - Nyse
  4. News Doximity, Inc.
  5. Doximity : Shares Soar in New York Stock Exchange Debut